KalVista Pharmaceuticals, Inc. (KALV) Earnings
NASDAQ·Healthcare·Biotechnology
$27.00
—
Mkt Cap $1.44B
Next Earnings
In 82 daysThu, Sep 3, 2026
EPS Estimate
-$0.39
6 analysts
Revenue Estimate
$38.34M
Q4 2026: missed by -122.58% on EPS, -64.29% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$1.44B
P/E
—
Fwd P/E
—
P/S
19.49
Rev TTM
—
EPS TTM
-$3.23